Ron Bentsur
2015 - Keryx Biopharmaceuticals
In 2015, Ron Bentsur earned a total compensation of $2.6M as Former Chief Executive Officer at Keryx Biopharmaceuticals, a 71% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,453,279 |
|---|---|
| Salary | $191,615 |
| Stock Awards | $966,158 |
| Total | $2,611,052 |
Bentsur received $1.5M in option awards, accounting for 56% of the total pay in 2015.
Bentsur also received $191.6K in salary and $966.2K in stock awards.
Rankings
In 2015, Ron Bentsur's compensation ranked 3,665th out of 13,638 executives tracked by ExecPay. In other words, Bentsur earned more than 73.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,665 out of 13,638 | 73rd |
Division Manufacturing | 1,337 out of 5,190 | 74th |
Major group Chemicals And Allied Products | 485 out of 1,854 | 74th |
Industry group Drugs | 387 out of 1,528 | 75th |
Industry Pharmaceutical Preparations | 305 out of 1,182 | 74th |
Source: SEC filing on April 15, 2016.
Bentsur's colleagues
We found five more compensation records of executives who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2015.
2015
Gregory Madison
Keryx Biopharmaceuticals
Chief Executive Officer
2015
John Neylan
Keryx Biopharmaceuticals
Chief Medical Officer
2015
James Oliviero
Keryx Biopharmaceuticals
Chief Financial Officer
2015
Brian Adams
Keryx Biopharmaceuticals
General Counsel
2015
Scott Holmes
Keryx Biopharmaceuticals